Interestingly, at this concentration, primary fibroblasts isolated from inflamed and noninflamed mucosa of IBD patients responded to PG reverting TNF-α dependent release of IL-6 and IL-8, and reducing metalloproteinase expression, indicating the capability of PG capability to revert fibroblast activation. This evidence concerns the gene CXCL8 and inflammatory bowel disease.